CN Patent

CN105997856A — 盐酸羟甲唑啉滴眼液及其制备方法

Assigned to Individual · Expires 2016-10-12 · 10y expired

What this patent protects

本发明提出了盐酸羟甲唑啉滴眼液及其制备方法。根据本发明的实施例的盐酸羟甲唑啉滴眼液，对眼部刺激性小、使用舒适、药品质量稳定、疗效更加持久。

USPTO Abstract

本发明提出了盐酸羟甲唑啉滴眼液及其制备方法。根据本发明的实施例的盐酸羟甲唑啉滴眼液，对眼部刺激性小、使用舒适、药品质量稳定、疗效更加持久。

Drugs covered by this patent

oxymetazoline-hydrochloride (OXYMETAZOLINE HYDROCHLORIDE)

Patent Metadata

Patent number: CN105997856A
Jurisdiction: CN
Classification: —
Expires: 2016-10-12
Drug substance claim: No
Drug product claim: No
Assignee: Individual
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.